Amy Bachrodt - Jan 30, 2025 Form 3 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role
SVP, Finance
Signature
/s/ Courtney Phillips, as attorney-in-fact
Stock symbol
MAZE
Transactions as of
Jan 30, 2025
Transactions value $
$0
Form type
3
Date filed
1/30/2025, 04:21 PM
Next filing
Sep 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MAZE Common Stock 13K Jan 30, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 2.52K $10.42 Direct F1
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 7.78K $10.42 Direct F2
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 10.4K $10.42 Direct F3
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 5.19K $10.42 Direct F4
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 9.85K $10.42 Direct F5
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 33.7K $10.42 Direct F6
holding MAZE Stock Option (Right to Buy) Jan 30, 2025 Common Stock 41.5K $10.42 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on March 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F2 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F3 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on March 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F4 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on November 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F5 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F6 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F7 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.